Alkermes
Bhaskar Rege, Ph.D. serves as Alkermes’ Senior Vice President of Pharmaceutical and Early Stage Clinical Development. In this role, Dr. Rege leads the DMPK, Clinical Pharmacology, Bioanalytical Sciences, Translational Medicine, Non-Clinical Safety Evaluation and Pharmaceutical Development functions.
Dr. Rege has over 20 years of pharmaceutical experience in multiple therapeutic areas and has led over 30 clinical trials. Before joining Alkermes as Global Development Lead in 2017, Dr. Rege held several roles at Eisai Pharmaceuticals, including serving as the Global Head of Clinical Pharmacology and Translation Medicine. Prior to this role, he held various positions in clinical pharmacology at Bristol Myers Squibb and Seattle Genetics.
Dr. Rege earned a Ph.D. in Pharmaceutical Sciences from Virginia Commonwealth University and Bachelor of Pharmacy in Pharmaceutical Sciences from The Bombay College of Pharmacy.
This person is not in any offices
Alkermes
8 followers
Alkermes plc is a pharmaceutical manufacturing and biopharmaceutical company developing innovative medicines to help patients with serious chronic conditions.